Full Text View
Tabular View
No Study Results Posted
Related Studies
Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
This study is currently recruiting participants.
Verified December 2012 by Weill Medical College of Cornell University
Study NCT00968240   Information provided by Weill Medical College of Cornell University

First Received on August 26, 2009.   Last Updated on December 18, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glioblastoma Multiforme
Anaplastic Astrocytoma
Additional conditions recognized in this trial
Astrocytoma
Glioblastoma
More general conditions related to this trial
Glioma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Additional drug interventions recognized in this trial
Bevacizumab
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Weill Medical College of Cornell University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services